doi:10.1016/j.virs.2022.10.006

[1]
Yongran Wu, Ke Hong, Lianguo Ruan, Xiaobo Yang, Jiancheng Zhang, Jiqian Xu, Shangwen Pan, Lehao Ren, Lu Chen, Chaolin Huang, You Shang, 2020: Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study, Virologica Sinica, 35, 768-775. doi: 10.1007/s12250-020-00281-8
[2]
Lingqian Tian, Qiuhong Liu, Rongjuan Pei, Yingshan Chen, Chonghui Xu, Jielin Tang, Hao Sun, Kunpeng Liu, Qi Yang, Lei Yang, Leshan Li, Yongli Zhang, Yuan Zhou, Chao Shan, Xue Hu, Xinwen Chen, Yun Wang, 2022: Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release, Virologica Sinica, 37, 695-703. doi: 10.1016/j.virs.2022.06.008
[3]
Qianran Wang, Lu Peng, Yanqiu Nie, Yanni Shu, Huajun Zhang, Zidan Song, Yufeng Li, Hengrui Hu, Liushuai Li, Xi Wang, Jia Liu, Jiang Li, Zhengli Shi, Fei Deng, Yu Guo, Yiwu Zhou, Bing Yan, Zhihong Hu, Manli Wang, 2023: Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo, Virologica Sinica, 38, 257-267. doi: 10.1016/j.virs.2022.12.007
[4]
Yang Zheng, Qing Zhang, Ashaq Ali, Ke Li, Nan Shao, Xiaoli Zhou, Zhiqin Ye, Xiaomin Chen, Shanshan Cao, Jing Cui, Juan Zhou, Dianbing Wang, Baidong Hou, Min Li, Mengmeng Cui, Lihua Deng, Xinyi Sun, Qian Zhang, Qinfang Yang, Yong li, Hui Wang, Yake Lei, Bo Yu, Yegang Cheng, Xiaolin Tong, Dong Men, Xian-En Zhang, 2021: Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months, Virologica Sinica, 36, 869-878. doi: 10.1007/s12250-021-00360-4
[5]
Mingqing Lu, Kunpeng Liu, Yun Peng, Zhe Ding, Yingwen Li, Alexander Tendu, Xue Hu, Ge Gao, Weiwei Guo, Hang Liu, Juhong Rao, Jiaxuan Zhao, Miaoyu Chen, Zhiming Yuan, Gary Wong, Chao Shan, Yanfeng Yao, Jiaming Lan, 2022: Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice, Virologica Sinica, 37, 581-590. doi: 10.1016/j.virs.2022.05.006
[6]
Sissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B.C. Kopecky, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Gernot Walder, 2022: The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro, Virologica Sinica, 37, 198-207. doi: 10.1016/j.virs.2022.01.029
[7]
Wei Chen, Pengmian Feng, Kewei Liu, Meng Wu, Hao Lin, 2020: Computational Identification of Small Interfering RNA Targets in SARS-CoV-2, Virologica Sinica, 35, 359-361. doi: 10.1007/s12250-020-00221-6
[8]
Xiao-Li Feng, Dandan Yu, Mi Zhang, Xiaohong Li, Qing-Cui Zou, Wentai Ma, Jian-Bao Han, Ling Xu, Cuixian Yang, Wang Qu, Zhong-Hua Deng, Junyi Long, Yanghaopeng Long, Mingkun Li, Yong-Gang Yao, Xing-Qi Dong, Jianxiong Zeng, Ming-Hua Li, 2022: Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates, Virologica Sinica, 37, 804-812. doi: 10.1016/j.virs.2022.09.007
[9]
Kai Wu, Dehe Wang, Junhao Wang, Yu Zhou, 2022: Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs, Virologica Sinica, 37, 813-822. doi: 10.1016/j.virs.2022.09.003
[10]
Bei Wang, Chongyang Zhang, Xiaobo Lei, Lili Ren, He Huang, Jianwei Wang, Zhendong Zhao, 2021: Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation, Virologica Sinica, 36, 890-900. doi: 10.1007/s12250-021-00369-9
[11]
Tiandan Xiang, Junzhong Wang, Xin Zheng, 2022: The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages, Virologica Sinica, 37, 786-795. doi: 10.1016/j.virs.2022.11.007
[12]
Yi Yan, Ke Wu, Jun Chen, Haizhou Liu, Yi Huang, Yong Zhang, Jin Xiong, Weipeng Quan, Xin Wu, Yu Liang, Kunlun He, Zhilong Jia, Depeng Wang, Di Liu, Hongping Wei, Jianjun Chen, 2021: Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing, Virologica Sinica, 36, 901-912. doi: 10.1007/s12250-021-00378-8
[13]
Xiaohui Zou, Shengrui Mu, Yeming Wang, Li Guo, Lili Ren, Xiaoyan Deng, Haibo Li, Jiankang Zhao, Yulin Zhang, Hui Li, Binghuai Lu, Chaolin Huang, Bin Cao, 2022: Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients, Virologica Sinica, 37, 30-37. doi: 10.1016/j.virs.2022.01.008
[14]
Chunchen Wu, Wenzhong Yang, Xiaoxue Wu, Tianzhu Zhang, Yaoyao Zhao, Wei Ren, Jianbo Xia, 2020: Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women, Virologica Sinica, 35, 305-310. doi: 10.1007/s12250-020-00227-0
[15]
Pingping Yao, Yachun Zhang, Yisheng Sun, Yulin Gu, Fang Xu, Bo Su, Chen Chen, Hangjing Lu, Dehui Wang, Zhangnv Yang, Biao Niu, Jiancai Chen, Lixia Xie, Lei Chen, Yajing Zhang, Hui Wang, Yuying Zhao, Yue Guo, Juncheng Ruan, Zhiyong Zhu, Zhenfang Fu, Dayong Tian, Qi An, Jianmin Jiang, Hanping Zhu, 2020: Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell, Virologica Sinica, 35, 348-350. doi: 10.1007/s12250-020-00241-2
[16]
Changhua Yi, Yongxiang Yi, Junwei Li, 2020: mRNA Vaccines: Possible Tools to Combat SARS-CoV-2, Virologica Sinica, 35, 259-262. doi: 10.1007/s12250-020-00243-0
[17]
Yafei Zhang, Changtai Wang, Mingfeng Han, Jun Ye, Yong Gao, Zhongping Liu, Tengfei He, Tuantuan Li, Mengyuan Xu, Luping Zhou, Guizhou Zou, Mengji Lu, Zhenhua Zhang, 2020: Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference, Virologica Sinica, 35, 758-767. doi: 10.1007/s12250-020-00273-8
[18]
Xinghai Zhang, Shaohong Chen, Zengguo Cao, Yanfeng Yao, Junping Yu, Junhui Zhou, Ge Gao, Ping He, Zhuo Dong, Jie Zhong, Jing Luo, Hongping Wei, Huajun Zhang, 2022: Increased pathogenicity and aerosol transmission for one SARS-CoV-2 B.1.617.2 Delta variant over the wild-type strain in hamsters, Virologica Sinica, 37, 796-803. doi: 10.1016/j.virs.2022.09.008
[19]
Zhenwei Liu, Xingui Tian, Wenkuan Liu, Yuting Xian, Weilue Chen, Rong Zhou, 2021: A Sensitive and High-Throughput Flow Cytometry-Based Assay for Measuring Antibody Neutralization of Human Adenovirus Type 3, Virologica Sinica, 36, 537-544. doi: 10.1007/s12250-020-00295-2
[20]
Fan Shen, Chun Liang, Cui-Xian Yang, Ying Lu, An-Qi Li, Ying Duan, Mi Zhang, Ren-Rong Tian, Xing-Qi Dong, Yong-Tang Zheng, Wei Pang, 2024: SARS-CoV-2 breakthrough infections following inactivated vaccine vaccination induce few neutralizing antibodies against the currently emerging Omicron XBB variants, Virologica Sinica, 39, 173-176. doi: 10.1016/j.virs.2023.11.007